162 related articles for article (PubMed ID: 24381417)
1. Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung Cancer.
Ghosh I; Bhattacharjee D; Das AK; Chakrabarti G; Dasgupta A; Dey SK
Indian J Clin Biochem; 2013 Jan; 28(1):24-9. PubMed ID: 24381417
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
Pina TC; Zapata IT; Hernández FC; López JB; Paricio PP; Hernández PM
Clin Chim Acta; 2001 Mar; 305(1-2):27-34. PubMed ID: 11249919
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
5. Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.
Antonangelo L; Sales RK; Corá AP; Acencio MM; Teixeira LR; Vargas FS
Curr Oncol; 2015 Oct; 22(5):e336-41. PubMed ID: 26628873
[TBL] [Abstract][Full Text] [Related]
6. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer.
Sanguinetti CM; Riccioni G; Marchesani F; Pela R; Cecarini L
Monaldi Arch Chest Dis; 1995 May; 50(3):177-82. PubMed ID: 7663486
[TBL] [Abstract][Full Text] [Related]
9. [A case of pulmonary alveolar proteinosis with high levels of tumor markers].
Nakajima M; Tamada S; Yoshida K; Sugihara S; Okimoto N; Niki Y; Manabe T; Soejima R
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Nov; 32(11):1109-14. PubMed ID: 7815767
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid. A comparative study among patients with peripheral lung cancer, pneumonia, and healthy individuals.
de Diego A; Compte L; Sanchis J; Enguidanos MJ; Marco V
Chest; 1991 Oct; 100(4):1060-3. PubMed ID: 1914558
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of broncho-alveolar lavage carcino-embronic antigen in carcinoma of lung.
Pothal S; Patil KP; Manjhi R; Dutta P
J Family Med Prim Care; 2019 May; 8(5):1725-1729. PubMed ID: 31198744
[TBL] [Abstract][Full Text] [Related]
15. The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
Dranka-Bojarowska D; Lewinski A; Lekstan A; Gajda M; Ciosek J; Mrowiec S
J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33571962
[TBL] [Abstract][Full Text] [Related]
16. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of epidermal growth factor, cancer antigen 125, and cancer antigen 15-3 in bronchoalveolar lavage fluid of lung cancer.
Sun S; Chen Z; Cao C; Wu B; Wang B; Yu Y; Chen Z; Hu Z; Deng Z
Curr Oncol; 2017 Jun; 24(3):e180-e184. PubMed ID: 28680284
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
19. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion.
Santotoribio JD; Del Valle-Vazquez L; García-de la Torre A; Del Castillo-Otero D; Lopez-Saez JB; Sanchez Del Pino MJ
PLoS One; 2019; 14(9):e0222616. PubMed ID: 31550262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
